Protect Your DTP Strategy

Send us Fan Mail Pharma is finally catching up to the on-demand world—offering direct-to-patient (DTP) services that promise convenience, faster delivery, and a more personalized experience. Major players like Pfizer, Lilly, and Novo Nordisk are leading the way, cutting out intermediaries like pharmacists, PBMs, and even traditional physicians. But convenience comes at a cost. By removing these safeguards, companies take on massive compliance liabilities. Telehealth prescribing raises serious...